Applying Guideline Updates and Real-World Experience in CLL: Experts Review State-of-the-Art Evidence and Address Clinical Challenges

Download slides from a live CCO symposium in which expert faculty discuss optimal treatment plans for patients with CLL/SLL while considering adverse events biomarkers comorbidities and patient preferences.

Share

Program Content

Activities

Frontline Therapy for CLL
Optimal Selection of Therapy for Treatment-Naive Chronic Lymphocytic Leukemia
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 09, 2021

Expires: December 08, 2022

Treating R/R CLL
Considerations in Selecting Therapy for Previously Treated Chronic Lymphocytic Leukemia
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 09, 2021

Expires: December 08, 2022

Future Directions in CLL
Near Future Directions in Treating CLL: Promising Agents and Combinations Under Investigation
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 09, 2021

Expires: December 08, 2022

<i>EP</i>: CLL Guidance
ExpressPoints:
Applying Guideline Updates and Real-World Experience in CLL
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 22, 2021

Expires: December 21, 2022

Faculty

cover img faculity

Asher Chanan-Khan, MD

Associate Professor of Oncology
Attending Physician
, Department of Medicine
Member, Department of Pharmacology and Therapeutics
Roswell Park Cancer Institute
Buffalo, New York

cover img faculity

Brian Hill, MD, PhD

Director, Lymphoid Malignancies Program
Staff Physician, Department of Hematology and Medical Oncology
Taussig Cancer Institute
Cleveland Clinic
Cleveland, Ohio

cover img faculity

Shuo Ma, MD, PhD

Professor of Medicine
Division of Hematology-Oncology
Department of Medicine
Robert H. Lurie Comprehensive Cancer Center
Northwestern University Feinberg School of Medicine
Chicago, Illinois

Provided by

ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca

BeiGene Ltd

Genentech, a member of the Roche Group

Janssen Biotech Pharmacyclics Abbvie